HR 1266
Combating Illicit Xylazine Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Combating Illicit Xylazine Act aims to address the growing problem of xylazine, a dangerous sedative and anesthetic drug, being misused and diverted into the illicit drug supply. The bill proposes scheduling xylazine as a Schedule III controlled substance, which would increase regulation and oversight. It also includes provisions to delay certain regulatory requirements related to xylazine manufacturing and distribution, and mandates a report to Congress on the drug’s prevalence and impact.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.